The Effect of Zanoterone (cas 107000-34-0), a Steroidal Androgen Receptor Antagonist, in Men with Benign Prostatic Hyperplasia

Add time:08/08/2019    Source:sciencedirect.com

PurposeZanoterone (100 to 800 mg.) versus placebo was studied in 463 patients with benign prostatic hyperplasia.

We also recommend Trading Suppliers and Manufacturers of Zanoterone (cas 107000-34-0). Pls Click Website Link as below: cas 107000-34-0 suppliers

Prev:Solid-state characterization of Zanoterone (cas 107000-34-0)
Next:Effect of surface modified kaolin on properties of polypropylene grafted maleic anhydride)